Preferential Autoimmune Response in Prostate Cancer to Cyclin B1 in a Panel of Tumor-Associated Antigens
Figure 4
Sensitivity and specificity of ELISA based on combined seven TAAs (cyclin B1, survivin, p53, RalA, DFS70/LEDGFp75, MDM2, and NPM1) for differentiating between PCa () and normal controls ().
